Andrea Younes
Neurology with Special Qualifications in Child Neurology · Cumberland, RINPI 1255728481
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Neurelis, Inc. accounts for 67.1% of it on its own, with 33 other manufacturers making up the rest.
Across 559 payments — averaging $47.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$18K
- UCB, Inc.$1K
- Corium, LLC$927
- Tris Pharma Inc$814
- SK Life Science, Inc.$786
- Ironshore Pharmaceuticals Inc.$653
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$15,39958%
- Travel & lodging$820%
- Food & beverage$10,86441%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 81 | $17,692 |
| UCB, Inc. | 58 | $1,191 |
| Corium, LLC | 69 | $927 |
| Tris Pharma Inc | 55 | $814 |
| SK Life Science, Inc. | 39 | $786 |
| Ironshore Pharmaceuticals Inc. | 29 | $653 |
| Supernus Pharmaceuticals, Inc. | 33 | $617 |
| AbbVie | 29 | $601 |
| Eisai Inc. | 28 | $422 |
| Jazz Pharmaceuticals Inc. | 16 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $311 |
| Livanova USA, Inc. | 11 | $219 |
| Biogen | 8 | $157 |
| Collegium Pharmaceutical, Inc. | 9 | $154 |
| Amneal Pharmaceuticals LLC | 11 | $153 |
| Catalyst Pharmaceuticals, Inc. | 7 | $150 |
| Immedica Pharma US, Inc. | 6 | $146 |
| Neos Therapeutics, LP | 6 | $117 |
| Alnylam Pharmaceuticals Inc. | 5 | $115 |
| Vertical Pharmaceuticals, LLC | 5 | $101 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Biomarin Pharmaceutical Inc. | 3 | $75 |
| Harmony Biosciences LLC | 2 | $73 |
| AstraZeneca | 4 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $70 |
| Avion Pharmaceuticals | 3 | $56 |
| Acadia Pharmaceuticals Inc | 2 | $48 |
| Biocodex, Inc. | 2 | $48 |
| Aquestive Therapeutics, Inc. | 2 | $41 |
| Aucta Pharmaceuticals, Inc. | 1 | $40 |
| Greenwich Biosciences, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Zogenix Inc. | 1 | $21 |
| Pyros Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurology with special qualifications in child neurology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ConcertaMethylphenidate Hcl | 22 | $9,479 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,608 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $1,259 |
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 14 | $1,210 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $1,040 |
| Amitriptyline Hcl | 11 | $241 |
| Clonazepam | 14 | $165 |
| Fluoxetine Hcl | 12 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $311 | $4,60812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neurology with special qualifications in child neurology providers in Rhode Islandon file to place this against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Cumberland
- Maria YounesCumberland$13K
- John GaitanisProvidence$45K
- Juan CantonWarwick$3K
- Luca BartoliniProvidence$798
- Duyu NieProvidence$389
- Tomo TaruiProvidence$107
- Gita HarappanahallyProvidence$17
- Ana Albuja PonceProvidence$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.